Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00436800
Status:
COMPLETED
Last Update Posted:
2009-09-18
First Post:
2007-02-16
Brief Title:
Gemcitabine and Oxaliplatin GEMOX in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
Sponsor:
Organization:
Sanofi